Európska únia -
slovenčina -
EMA (European Medicines Agency)
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imunitný séra a imunoglobulíny, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
Európska únia -
slovenčina -
EMA (European Medicines Agency)
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - imunitný séra a imunoglobulíny, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
Európska únia -
slovenčina -
EMA (European Medicines Agency)
hetlioz
vanda pharmaceuticals netherlands b.v. - tasimelteon - poruchy spánku, cirkadiánny rytmus - psycholeptika - hetlioz je indikovaný na liečbu 24-hodinovej poruchy spánku (non-24) u úplne slepých dospelých.
Slovensko -
slovenčina -
ŠÚKL (Štátny ústav pre kontrolu liečiv)
kvapky ušné auridol
emergopharm sp. o.o. sp.k józefa pilsudskiego 11 055 10 poľsko -